MK-5108 : A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
Maraviroc : Management of anticoagulation in patients with human immunodeficiency virus/acquired immunodeficiency virus☆
Tirzepatide : Evidence-based weight loss interventions: Individualized treatment options to maximize patient outcomes
Harmine : Synthesis and Antibacterial Study of Novel Harmine Derivatives and Tetrahydro-β-Carboline Derivatives In Vitro
XL765 : Dual PI3K/mTOR Inhibitor, XL765, suppresses glioblastoma growth by inducing ER stress-dependent apoptosis
Elsubrutinib : Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
Bindarit : Critical Role of Monocyte Recruitment in Optic Nerve Damage Induced by Experimental Optic Neuritis
S-Adenosyl-L-homocysteine : Impact of the MTHFR C677T polymorphism on one-carbon metabolites: Evidence from a randomised trial of riboflavin supplementation